🇺🇸 Levetiracetam Tablets in United States

342 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 67 reports (19.59%)
  2. Seizure — 64 reports (18.71%)
  3. Dizziness — 38 reports (11.11%)
  4. Convulsion — 35 reports (10.23%)
  5. Headache — 27 reports (7.89%)
  6. Somnolence — 26 reports (7.6%)
  7. Fatigue — 24 reports (7.02%)
  8. Product Substitution Issue — 23 reports (6.73%)
  9. Condition Aggravated — 19 reports (5.56%)
  10. Feeling Abnormal — 19 reports (5.56%)

Source database →

Frequently asked questions

Is Levetiracetam Tablets approved in United States?

Levetiracetam Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Levetiracetam Tablets in United States?

Gitte Moos Knudsen is the originator. The local marketing authorisation holder may differ — check the official source linked above.